Could a daily pill fight Cancer's devastating weight loss?
NCT ID NCT04844970
Summary
This study tested whether a daily pill called anamorelin could help prevent severe weight loss and poor appetite in people with advanced pancreatic cancer who were starting chemotherapy. The goal was to see if the drug could help patients maintain their weight and strength to better tolerate treatment. The trial was terminated early after enrolling only 4 of a planned 100 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lahey Hospital & Medical Center
Burlington, Massachusetts, 01805, United States
Conditions
Explore the condition pages connected to this study.